OTC Markets OTCPK - Delayed Quote USD

Xtacy Therapeutics Corp. (XTCYF)

0.0400 0.0000 (0.00%)
As of June 3 at 11:30 AM EDT. Market Open.
Currency in CAD All numbers in thousands
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Total Revenue
46.0930
21.8250
--
--
101.8720
--
Cost of Revenue
3.5030
2.2850
2.6670
1.5120
--
--
Gross Profit
42.5900
19.5400
-2.6670
-1.5120
101.8720
--
Operating Expense
880.4570
939.6730
1,375.0050
3,878.8950
696.3130
--
Operating Income
-837.8670
-920.1330
-1,377.6720
-3,880.4070
-594.4410
--
Net Non Operating Interest Income Expense
--
-1.1320
-1.9220
-1.5710
-1.9500
--
Other Income Expense
--
401.3290
10.8670
298.0510
-778.5980
--
Pretax Income
-434.7810
-519.9360
-1,368.7270
-3,583.9270
-1,374.9890
--
Net Income Common Stockholders
-434.7810
-519.9360
-1,368.7270
-3,583.9270
-1,374.9890
--
Diluted NI Available to Com Stockholders
-434.7810
-519.9360
-1,368.7270
-3,583.9270
-1,374.9890
--
Basic EPS
-0.01
-0.01
-0.05
-0.23
-0.10
--
Diluted EPS
-0.01
-0.01
-0.05
-0.23
-0.10
--
Basic Average Shares
51,192.4720
43,551.2510
27,153.3760
15,868.4920
13,834.6230
--
Diluted Average Shares
51,192.4720
43,551.2510
27,153.3760
15,868.4920
13,834.6230
--
Total Operating Income as Reported
-883.9600
-943.0900
-1,379.5940
-3,881.9780
-698.2630
--
Rent Expense Supplemental
--
--
13.5720
9.8780
3.5390
--
Total Expenses
883.9600
941.9580
1,377.6720
3,880.4070
696.3130
--
Interest Expense
2.6220
--
--
--
--
2.6220
Net Interest Income
--
-1.1320
-1.9220
-1.5710
-1.9500
--
Net Income from Continuing & Discontinued Operation
-434.7810
-519.9360
-1,368.7270
-3,583.9270
-1,374.9890
--
Normalized Income
-837.8670
-921.2650
-1,379.5940
-3,881.9780
-526.6820
--
EBIT
-837.8670
-920.1330
-1,377.6720
-3,880.4070
-594.4410
--
EBITDA
-837.8670
-920.1330
-1,377.6720
-3,880.4070
-594.4410
--
Reconciled Cost of Revenue
3.5030
2.2850
2.6670
1.5120
--
--
Net Income from Continuing Operation Net Minority Interest
-434.7810
-519.9360
-1,368.7270
-3,583.9270
-1,374.9890
--
Total Unusual Items Excluding Goodwill
403.0860
401.3290
10.8670
298.0510
-848.3070
--
Total Unusual Items
403.0860
401.3290
10.8670
298.0510
-848.3070
--
Normalized EBITDA
-1,240.9530
-1,321.4620
-1,388.5390
-4,178.4580
253.8660
--
9/30/2019 - 8/27/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers